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Introduction
The exact functional relationship between cell cycle arrest, 
senescence and autophagy remains unknown.1-9 Both senes-
cence and autophagy are thought to play key mechanistic 
roles in the development of multiple aging-associated diseases, 
and especially human cancers.10,11 Thus, understanding senes-
cence and autophagy has wide clinical implications, for both 
regenerative medicine and cancer prevention. Two relevant 
mechanistic questions are: (1) Is autophagy sufficient to induce 
senescence? and, conversely, (2) Is senescence sufficient to 
induce autophagy?
Here, we investigated the compartment-specific role of cell cycle arrest and senescence in breast cancer tumor growth. 
For this purpose, we generated a number of hteRt-immortalized senescent fibroblast cell lines overexpressing CDK 
inhibitors, such as p16(INK4A), p19(ARF) or p21(WAF1/CIp1). Interestingly, all these senescent fibroblast cell lines showed 
evidence of increased susceptibility toward the induction of autophagy (either at baseline or after starvation), as well as 
significant mitochondrial dysfunction. Most importantly, these senescent fibroblasts also dramatically promoted tumor 
growth (up to ~2-fold), without any comparable increases in tumor angiogenesis. Conversely, we generated human breast 
cancer cells (MDA-MB-231 cells) overexpressing CDK inhibitors, namely p16(INK4A) or p21(WAF1/CIp1). Senescent MDA-
MB-231 cells also showed increased expression of markers of cell cycle arrest and autophagy, including β-galactosidase, as 
predicted. Senescent MDA-MB-231 cells had retarded tumor growth, with up to a near 2-fold reduction in tumor volume. 
thus, the effects of CDK inhibitors are compartment-specific and are related to their metabolic effects, which results in 
the induction of autophagy and mitochondrial dysfunction. Finally, induction of cell cycle arrest with specific inhibitors 
(pD0332991) or cellular stressors [hydrogen peroxide (H2O2) or starvation] indicated that the onset of autophagy and 
senescence are inextricably linked biological processes. the compartment-specific induction of senescence (and hence 
autophagy) may be a new therapeutic target that could be exploited for the successful treatment of human breast cancer 
patients.
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Recent studies have shown that senescence and autophagy 
may be part of the same metabolic program, known as the 
autophagy-senescence transition (AST).10-21 In support of this 
notion, recombinant expression of autophagy genes (BNIP3, 
Cathepsin B or ATG16L1) in stromal fibroblasts is sufficient to 
induce the onset of constitutive autophagy as well as the devel-
opment of senescence.12,13 In this model, “leaky” lysosomes 
drive the onset of aging and senescence in response to cellular 
stress.22,23 Thus, autophagy is indeed sufficient to induce senes-
cence.22,23 The AST also leads to mitophagy, due to the onset of 
mitochondrial dysfunction, resulting in a cellular shift toward 
aerobic glycolysis and ketone production.12,13 Importantly, these 
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sufficient to induce autophagy and to drive the onset of mitophagy, 
as well as mitochondrial dysfunction. Thus, we validated the exis-
tence of the senescence-autophagy transition (SAT). Importantly, 
these CDK-overexpressing fibroblasts also significantly promoted 
tumor growth, without an increase in angiogenesis.
As such, our current results provide a new genetically tractable 
model for understanding the metabolic role of “host aging” in 
promoting tumor growth and metastasis by providing a “fertile,” 
local microenvironment.
Conversely, overexpression of CDK-inhibitor proteins in 
breast cancer cells resulted in reduced tumor growth, secondary 
to the induction of autophagy in tumor cells. This may provide 
an innovative targeted approach for new avenues of therapeutic 
intervention.
Finally, using a pharmacological approach relying on specific 
inhibitors (PD0332991) and cellular stressors (hydrogen perox-
ide or starvation), we show that autophagy and senescence are 
two closely linked biological phenomena, implying that they are 
part of the same coordinated metabolic program.
Results
Cell cycle arrest, autophagy and senescence are three closely 
linked biological processes. To experimentally assess the rela-
tionship between cell cycle arrest, senescence and autophagy, we 
first used a pharmacological approach to induce cell cycle arrest 
with the CDK4/6 chemical inhibitor, PD0332991.43,44 For this 
purpose, hTERT-immortalized fibroblasts were treated with 
PD0332991 (0.1, 0.5 and 1 μM) for a period of 36 h, and then 
the cells were subjected to biochemical analysis.
Figure 1 shows that treatment with PD0332991 dramatically 
inhibits RB-phosphorylation, as expected, resulting in the upreg-
ulation of markers of cell cycle arrest, such as CDK inhibitors 
(p16 and p21), as well as markers of senescence (β-galactosidase) 
and autophagy (LC3-I/II). Thus, the induction of cell cycle 
arrest is closely linked to the onset of senescence and autophagy.
Next, we assessed the response to a well-established cellular 
stress, hydrogen peroxide (H2O2; 300 μM), which is known to 
induce oxidative stress, senescence and autophagy. Then, we fol-
lowed changes in markers of the cell cycle and autophagy, over a 
time course of 8 d post-treatment. Figure 2A shows that H202-
treatment induces the upregulation of markers of cell cycle arrest 
and senescence (p53, p21, β-galactosidase), as well the downreg-
ulation of markers of cell proliferation (phospho-RB, PCNA), 
within the first 2–3 d post-treatment. Figure 2B indicates that 
H2O2 treatment induces a panel of lysosomal (Lamp-1, cathep-
sin B) and autophagy/mitophagy markers (Beclin-1, BNIP3, 
LC3-I/II) within 4–6 d post-treatment.
Finally, we determined the response to another cellular stress 
closely associated with autophagy, i.e., amino acid starvation. A 
preliminary time course study indicated that autophagy peaked 
at 3 h and cell cycle arrest peaked at 4 h. Figure 3 (left panel) 
shows that at 3 h post-starvation, several markers of autoph-
agy (Lamp-1, BNIP3 and LC3) are upregulated. Similarly, 
Figure 3 (right panel) illustrates that at 4 h post-starvation, a panel 
of markers associated with cell cycle arrest and senescence (p16, 
autophagic-senescent fibroblasts undergo catabolism and locally 
produce high-energy mitochondrial fuels (such as L-lactate, 
ketone bodies and glutamine).12,13 These mitochondrial fuels can 
then act as onco-catabolites, driving anabolic tumor growth and 
cancer cell metastasis.24-36 This simple energy-transfer mecha-
nism may also be very important for tumor initiation, especially 
under conditions where tumor angiogenesis has yet to occur, pro-
viding a “fertile ground” for tumor growth.37-42
However, it remains unknown if cell cycle arrest and senes-
cence are also sufficient to drive the onset of autophagy, resulting 
in the senescence-autophagy transition (SAT). If this was indeed 
the case, then the SAT would explain why chronological aging 
is one of the single most important risk factors for the develop-
ment of human cancers. It would establish, unequivocally, that 
chronological aging directly generates high-energy nutrients 
(onco-catabolites) to “feed” cancer cells.
Here, we used a genetic approach to test the hypothesis that cell 
cycle arrest and senescence were sufficient to induce an autopha-
gic phenotype in cancer-associated fibroblasts. To test this idea, 
we created a panel of hTERT-immortalized fibroblast cell lines 
that recombinantly overexpress well-known CDK inhibitors, 
such as p16(INK4A), p19(ARF), smARF and p21(WAF1/CIP1). 
Interestingly, overexpression of CDK-inhibitor proteins was 
Figure 1. treatment with pD0332991, a CDK4/6-inhibitor, induces mark-
ers of senescence and autophagy. hteRt-BJ1 fibroblasts were incu-
bated with pD0332991 (0.1, 0.5 and 1 μM) for 36 h before the cells were 
harvested and subjected to immunoblot analysis with specific antibody 
probes. Note that pD0332991 effectively inhibits the phosphorylation 
of RB, as predicted. In addition, pD0332991 induces the upregula-
tion of three markers of senescence [p21(WAF1/CIp1), p16(INK4A) and 
β-galactosidase]. Similarly, LC3 expression (an autophagy marker) is 
progressively upregulated. Blotting with β-actin is shown as a control 
for equal protein loading.
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We further validated that that both smARF- and p19(ARF)-





induced senescence, using β-galactosidase as a marker. Figure 6 
shows representative images and corresponding quantitation, 
p19, p21, p53, β-galactosidase) are all upregulated. Conversely, at 
the same time point, markers of cell proliferation are downregu-
lated (phospho-RB and cyclin D1).
In summary, based on this analysis, we conclude that cell 
cycle arrest, autophagy and senescence are three closely linked 
conserved biological processes, such that autophagy induces 
senescence and, conversely, senescence induces autophagy.
p19(ARF) and smARF drive the onset of senescence and 
autophagy in cancer-associated fibroblasts, metabolically 
promoting tumor growth, without increased angiogenesis. 
p19(ARF) and its closely related truncated isoform, smARF, are 
best known to function as CDK inhibitors.45-51 To study the poten-
tial metabolic effects of p19(ARF) and smARF, they were both 
stably expressed in hTERT-immortalized fibroblasts. Figure 4A 
indicates that we successfully generated stable cell lines express-
ing either p19(ARF) or smARF. Since they are both continuously 
degraded by the proteasomal machinery, we used treatment with 
the proteasomal-inhibitor MG-132 (10 μM for 16 h) to facilitate 
their detection. In addition, Figure 4B indicates that p19(ARF)- 
and smARF-expressing fibroblasts are more susceptible to the 
induction of p16 and p21 under conditions of H2O2 exposure, 
as expected. Under these conditions (Fig. 4C), we also observed 
a loss of Cav-1 expression, suggesting its lysosomal degradation 
by autophagy.
To validate the hypothesis that both smARF and p19(ARF) 
expression increase the susceptibility to autophagy, these stable 




 and cultured 
for an additional 5 d to allow the onset of senescence. Figure 5 
shows that the expression of either smARF or p19(ARF) increases 
the levels of a panel of autophagy markers (Lamp-1, Beclin-1, 
BNIP3, cathepsin B, LC3 and legumain), in accordance with our 
hypothesis.
Figure 3. Acute starvation induces markers of autophagy and senes-
cence. After 3 h of acute starvation with Hepes-buffered HBSS, several 
markers of autophagy were increased (Lamp-1, BNIp3, LC3). Similarly, 
after 4 h of acute starvation with HBSS, a panel of markers for cell cycle 
arrest [p21(WAF1/CIp1), p19(ARF), p16(INK4A), p53, β-galactosidase] 
were all increased. Conversely, markers of cell cycle progression were 
significantly decreased (phospho-RB and cyclin D1). Blotting with 
β-actin is shown as a control for equal protein loading.
Figure 2. Acute treatment with hydrogen peroxide (H2O2) induces markers of senescence and autophagy. hteRt-BJ1 fibroblasts were treated for 1 h 
with H2O2 (300 μM) and then cultured for 0–8 d. then, at each time point, the cells were harvested and subjected to immunoblot analysis. Blotting 
with β-actin is shown as a control for equal protein loading. (A) Markers of the cell cycle and senescence. Note that several markers of cell cycle arrest 
and senescence were increased at days 2 and 3 post-treatment [p53, p21(WAF1/CIp1) and β-galactosidase], while markers of cell cycle progression 
are decreased (phospho-RB and pCNA). (B) Markers of autophagy and mitophagy. Note that several markers of autophagy, mitophagy and lysosomes 
(Lamp-1, Beclin-1, BNIp3, cathepsin B and LC3) were increased, mainly at days 4–6 post-treatment.
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Figure 4. Generating stable fibroblast cell lines which constitutively 
express smARF and p19(ARF). hteRt-BJ1 fibroblasts were transduced 
with lenti-viral vectors encoding smARF or p19(ARF) and then selected 
for puromycin-resistance. Control fibroblasts transduced with the 
empty vector (eV; Lv-105) were produced in parallel. then, these stable 
cell lines were subjected to biochemical analysis. Blotting with β-actin 
is shown as a control for equal protein loading. (A) treatment with the 
proteasome inhibitor MG-132. After overnight treatment (16 h) with 
MG-132 (10 μM), the cells were harvested and subjected to immunoblot 
analysis. Note that both smARF and p19(ARF) were stably expressed. 
(B) Acute treatment with H2O2. After acute treatment with H2O2 (300 
μM), the fibroblasts were cultured for an additional 5 d to allow the 
onset of senescence. Note that fibroblasts transduced with smARF or 
p19(ARF) show the upregulation of p16(INK4A) and/or p21 (WAF1/CIp1), 
other CDK inhibitors. (C) As in (B), except the expression of Cav-1 was 
assessed. Note the 2-fold reduction in Cav-1 expression.
Figure 5. Both smARF and p19(ARF) expression increases the suscep-
tibility of fibroblasts to the onset of autophagy. Stable fibroblast cell 
lines were acutely treated with H2O2 and cultured for an additional 5 d. 
then, the expression of autophagy markers was assessed. Note that the 
expression of either smARF or p19(ARF) increases the levels of a panel 
of autophagy markers (Lamp-1, Beclin-1, BNIp3, cathepsin B, LC3 and 
legumain). Blotting with β-actin is shown as a control for equal protein 
loading.
fibroblast cell lines were co-injected with MDA-MB-231(GFP) 
breast cancer cells into the flanks of immunodeficient mice. 
Then, tumor growth was followed for a period of 30 d post-
injection. Figure 8A and B show that fibroblasts overexpressing 
smARF or p19(ARF) resulted in a near 2-fold increase in tumor 
growth. However, CD31 immunostaining indicated that angio-
genesis could not account for the observed increase in tumor 
growth (Fig. 8C).
p16(INK4A) and p21(WAF1/CIP1) induce senescence and 
autophagy in cancer-associated fibroblasts, metabolically pro-
moting tumor growth, without increased angiogenesis. To fur-
ther assess the relationship between cell cycle arrest, autophagy 
and senescence, we next focused on the metabolic effects of 
two other well-known CDK inhibitors, namely p16(INK4A) 
and p21(WAF1/CIP1). For this purpose, we generated hTERT 
fibroblast cell lines overexpressing p16(INK4A) and p21(WAF1/
CIP1). Figure 9 directly shows that p16(INK4A) and p21(WAF1/
CIP1) were effectively stably expressed in hTERT-BJ1 cells. As 
predicted, this resulted in the corresponding upregulation of a 
panel of markers of cell cycle arrest and senescence (p16, p21, p53 
and β-galactosidase).
In further support of the notion that senescence and autoph-
agy are part of the same metabolic program, Figure 10 shows that 
p16(INK4A)- and p21(WAF1/CIP1)-expressing fibroblasts are 
more autophagic, both at baseline and under conditions of starva-
tion (Fig. 10A and B), and they also show a tendency toward cell 
hypertrophy, consistent with a senescent phenotype (Fig. 10C). 
Overexpression of markers of autophagy (Lamp-1 and BNIP3) 
is observed, especially in cells overexpressing p21(WAF1/CIP1). 
Similarly, after 12 h of starvation in Hepes-buffered HBSS, 
the overexpression of markers of autophagy (LC3-I/II) is 
indicating that smARF and p19(ARF) expression increase 
β-galactosidase positivity by > 3-fold. In addition, under condi-
tions of hypoxia, p19(ARF) also induces a > 2-fold increase in 
L-lactate production, consistent with the onset of mitophagy and 
mitochondrial dysfunction (Fig. 7). Thus, p19(ARF)-induced 
cell cycle arrest increases the susceptibility of cells toward the 
onset of stress-induced cellular senescence, resulting in the acti-
vation of autophagic processes and a metabolic shift toward 
glycolysis.
Most importantly, fibroblasts overexpressing smARF or 
p19(ARF) effectively promoted tumor growth (Fig. 8). Stable 
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with mitophagy and mitochondrial dysfunction, we assessed the 
status of mitochondrial oxidative phosphorylation (OXPHOS). 
Figure 11 shows that fibroblasts overexpressing p16(INK4A) 
and p21(WAF1/CIP1) both show significant changes in mito-
chondrial OXPHOS components. Importantly, dramatic reduc-
tions in several OXPHOS complex components was observed, 
especially complex I, III and V. Similarly, reductions were also 
observed in complex II and IV, but to a lesser extent. This is 
Figure 6. Both smARF and p19(ARF) expression increases the suscep-
tibility of fibroblasts to the onset of senescence. Stable fibroblast cell 
lines were acutely treated with H2O2 and cultured for an additional 5 d. 
then, the expression of β-galactosidase activity was assessed. Note that 
the expression of either smARF or p19(ARF) increases β-galactosidase 
activity by ~3-fold. Representative images are shown in (A), and quanti-
tation is presented in (B).
Figure 7. p19(ARF) increases L-lactate production. Stable fibroblast cell 
lines were subjected to chronic hypoxia for 48 h. then, the levels of L-
lactate that accumulated in the tissue-culture media were assessed and 
normalized to the amount of total cellular protein. Note that p(19)ARF 
expression increases L-lactate accumulation by > 2-fold.
detected, especially in cells overexpressing p21(WAF1/CIP1). 
However, cell hypertrophy is observed most significantly in fibro-
blasts overexpressing p16(INK4A).
As strong BNIP3 overexpression was observed in p16- and 
p21-overexpressing fibroblasts, and BNIP334,52-55 is associated 
Figure 8. Fibroblasts overexpressing smARF or p19(ARF) promote tu-
mor growth. Stable fibroblast cell lines were co-injected with MDA-MB-
231(GFp) breast cancer cells into the flanks of immunodeficient mice. 
then, tumor growth was followed for a period of 30 d post-injection. (A) 
shows the time course of tumor growth and (B) shows the final tumor 
volume at sacrifice, which resulted in a near 2-fold increase in tumor 
growth. (C) shows the results CD31 immunostaining, indicating that an-
giogenesis cannot account for the observed increase in tumor growth.
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consistent with mitochondrial dysfunction and a shift toward 
glycolysis.
We also determined the tumor-promoting activity of p16- and 
p21-senescent fibroblasts. These stable fibroblast cell lines were 
co-injected with MDA-MB-231(GFP) breast cancer cells into the 
flanks of immunodeficient mice. Then, tumor growth was fol-
lowed for a period of 4 wk post-injection. Figure 12A shows the 
final tumor volume at sacrifice, which resulted in a near 2-fold 
increase in tumor growth. Figure 12B illustrates that tumor-
associated CD31 immunostaining is not elevated, indicating that 
angiogenesis does account for the increased tumor growth. Thus, 
senescent-autophagic fibroblasts promote tumor growth, inde-
pendently of neo-angiogenesis.
p16(INK4A) and p21(WAF1/CIP1) induce senescence 
and autophagy in breast cancer cells, metabolically inhib-
iting tumor growth. To examine the compartment-specific 
effects of senescence and autophagy on tumor growth, we also 
created MDA-MB-231 breast cancer cell lines overexpress-
ing p16(INK4A) and p21(WAF1/CIP1). Figure 13 shows that 
we successfully generated MDA-MB-231 breast cancer cells 
overexpressing p16 or p21, which resulted in the induction of 
β-galactosidase, an established marker of cell cycle arrest and 
senescence.
Morphologically, MDA-MB-231 cells overexpressing 
p16(INK4A) and p21(WAF1/CIP1) also appeared more hyper-
trophic and expressed increased β-galactosidase activity, consis-
tent with a senescence phenotype (Fig. 14).
Figure 9. Generating stable fibroblast cell lines, which constitutively 
express p16(INK4A) and p21(WAF1/CIp1). hteRt-BJ1 fibroblasts were 
transduced with lenti-viral vectors encoding p16(INK4A) and p21(WAF1/
CIp1) and then selected for puromycin-resistance. Control fibroblasts 
transduced with the empty vector (eV; Lv-105) were produced in 
parallel. then, these stable cell lines were subjected to biochemical 
analysis. Note that after 6 d of culture, the overexpression of markers of 
cell cycle arrest and senescence [p16(INK4A, p21(WAF1/CIp1), p53 and 
β-galactosidase] is observed. Blotting with β-actin is shown as a control 
for equal protein loading.
Figure 10. Stable fibroblast cell lines, which constitutively express 
p16(INK4A) and p21(WAF1/CIp1), show the onset of increased autopha-
gy and/or cell hypertrophy. (A) Autophagy at baseline. Note that after 6 
d of culture, the overexpression of markers of autophagy (Lamp-1 and 
BNIp3) is observed, especially in cells overexpressing p21(WAF1/CIp1). 
Blotting with β-actin is shown as a control for equal protein loading. (B) 
Autophagy after starvation. Note that after 12 h of starvation in Hepes-
buffered HBSS, the overexpression of markers of autophagy (LC3-I/II) is 
observed, especially in cells overexpressing p21(WAF1/CIp1). Blotting 
with β-actin is shown as a control for equal protein loading. (C) Cell hy-
pertrophy. Note that after 2 d of culture, cell hypertrophy is observed, 
especially in cells overexpressing p16(INK4A).
Figure 15 illustrates that MDA-MB-231 cells, which over-
express p16(INK4A) and p21(WAF1/CIP1), undergo increased 
authophagy, either at baseline (Lamp-1, BNIP3, LC3-I/II) or 
under conditions of starvation for 12 h with HBSS (Beclin-1, and 
cathepsin B). Therefore, cell cycle arrest, senescence and autoph-
agy in cancer cells are all part of the same metabolic program.
Most importantly, MDA-MB-231 cells, which overexpress 
p16(INK4A) and p21(WAF1/CIP1), show a near 2-fold reduc-
tion in tumor volume. Thus, senescence and autophagy in cancer 
cells metabolically inhibits tumor growth.
Discussion
Here, we investigated the existence of the senescence-autophagy 
transition (SAT), using a molecular genetic approach (Fig. 16). 
More specifically, we tested the hypothesis that chronological 
aging may facilitate the growth of tumors via the onset of cell cycle 
arrest and senescence, which, in turn, drives the induction of an 
autophagic program in stromal fibroblasts. Senescence-induced 
autophagy would provide a “fertilized” microenvironment to 
facilitate the growth of cancer cells via the paracrine production 
of high-energy mitochondrial fuels (such L-lactate) that can then 
function as onco-catabolites.41,42,56-60 These recycled nutrients 
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promote anabolic tumor growth by increasing mitochondrial 
metabolism (OXPHOS) in adjacent cancer cells.31-34,37-40,61-63
To test this hypothesis, we created a variety of hTERT-immor-
talized fibroblast cell lines stably overexpressing established CDK-
inhibitor proteins, such as p16(INK4A), p19(ARF), smARF and 
p21(WAF1/CIP1). Importantly, these cell lines overexpressing 
CDK inhibitors were clearly more sensitive to the induction of 
senescence and autophagy, especially under conditions of stress, 
such as hydrogen peroxide exposure and/or starvation. These 
CDK-inhibitor overexpressing cell lines also showed evidence 
of mitochondrial dysfunction, such as either increased L-lactate 
production or reductions in mitochondrial OXPHOS complexes 
as well as the upregulation of mitophagy markers, such as BNIP3. 
Thus, it appears that senescence and autophagy are two related 
faces of the same metabolic aging-associated program.
Interestingly, these CDK-inhibitor-overexpressing fibroblast 
cell lines also significantly promoted tumor growth, by up to 
2-fold, without any significant increases in neo-angiogenesis. 
Thus, senescent-autophagic fibroblasts have tumor growth-pro-
moting properties. Conversely, CDK-inhibitor protein expression 
in breast cancer cells significantly retarded tumor growth and was 
associated with the induction of markers of senescence, autoph-
agy and mitophagy in these epithelial cancer cells.
Pharmacological induction of cell cycle arrest, by using a 
chemical CDK4/6 inhibitor (PD0332991) or use of other rel-
evant cellular stressors (hydrogen peroxide and starvation), all 
had the same net effect, resulting in the induction of molecules 
associated both with senescence and autophagy. Thus, we have 
unequivocally established that these two biological processes are 
tightly linked.
Several previous studies have also highlighted the tumor-pro-
moting properties of senescent fibroblasts.9,64-66 For example, Dr. 
Judy Campisi’s group has shown that senescent fibroblasts directly 
promote tumor growth via the increased secretion of cytokines 
Figure 11. Fibroblast cell lines, which constitutively express p16(INK4A) 
and p21(WAF1/CIp1), show significant reductions in OXpHOS complex 
components. Note that after 6 d of culture, dramatic reductions in 
OXpHOS complex components is observed, especially complex I, III and 
V. Reductions were also observed in complex II and IV, but to a lesser 
extent. Blotting with β-actin is shown as a control for equal protein 
loading.
Figure 12. Fibroblasts overexpressing p16(INK4A) and p21(WAF1/CIp1) promote tumor growth in a paracrine fashion. Stable fibroblast cell lines were 
co-injected with MDA-MB-231(GFp) breast cancer cells into the flanks of immunodeficient mice. then, tumor growth was followed for a period of 4 
wk post-injection. (A) shows the final tumor volume at sacrifice, which resulted in a near 2-fold increase in tumor growth. (B) shows the results CD31 
immunostaining, indicating that angiogenesis cannot account for the observed increase in tumor growth.
and chemokines.9,64-66 This is known as SASP, the senescence-
associated secretory phenotype. However, Dr. Campisi’s group 
has also shown that SASP is actually not required for the tumor-
promoting activity of senescent fibroblasts,64 implying the exis-
tence of another related or independent paracrine mechanism. 
Thus, the senescence-autophagy transition (SAT) may represent 
another mechanism by which senescent fibroblasts effectively 
promote tumor growth.
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previous studies have shown that tumor 
cells induce the activation of NFκB in 
cancer-associated fibroblasts via oxidative 
stress, resulting in cytokine production and 
a shift toward autophagy and glycolytic 
metabolism.24,30,34,35,67,68 This is essentially 
the same phenotype as the SASP and SAT, 
as oxidative stress is a strong inducer of both 
senescence and autophagy. In fact, increased 
protein synthesis and the secretion of cyto-
kines are known to occur during autophagy 
as a protective response against excessive 
protein degradation and apoptosis.11,69
Our current studies on the tumor-
promoting effects of p16(INK4A) fibro-
blasts may also explain recent biomarker 
data showing that an increase in stromal 
p16(INK4A) levels in human DCIS lesions 
(a precursor to full-blown breast cancer) 
dramatically increases the hazard ratio for 
recurrence by nearly 9-fold (p < 0.0001).70 
Thus, senescent-autophagic fibroblasts may 
be critical for “fueling” tumor initiation, 
progression and cancer recurrence. As such, 
our findings have important clinical and 
translational implication for future bio-
marker discovery and treatment stratification in DCIS and breast 
cancer patients.
Materials and Methods
Materials. Commercially available antibodies used were as fol-
lows: β-actin (Sigma-Aldrich, #A5441); Cav-1 mAb 2297 
(BD Transduction Laboratories, #610406); Beclin1 (Novus 
Biologicals, #NBP1-00085); BNIP3 (Abcam, #ab10433); 
BNIP3L (Abcam, #ab8399); Beta-galactosidase (GLB1; Abcam, 
#ab55176); p53 (Ab-6; Calbiochem, #OP43); Cathepsin B 
(FL-339) (Santa Cruz, #sc-13985); Lamp-1 (E-5) (Santa Cruz, 
#sc-17768); LC3B (Abcam, #ab48394); legumain (Santa Cruz, 
#sc-67163); p21 (H-164 or F-5) (Santa Cruz, #sc-756 or #sc-
6246); p19 (DCS-240) (Santa Cruz, #sc-53639); p16 (H-156) 
(Santa Cruz, #sc-759); cyclin D1 (Thermo Scientific, #MS-210) 
and OXPHOS (MitoSciences, #MS601). Lenti-viral vectors 
containing full-length cDNAs encoding various CDK-inhibitor 
genes [p16(INK4A), p19(ARF) and p21(WAF1/CIP1)] were all 
obtained commercially from GeneCopoeia. PD0332991 (the 
specific CDK4/6-inhibitor; #S1116) was obtained from Selleck 
Chemicals, Inc.
Cell culture. Immortalized human fibroblasts (hTERT-BJ1 
cells) and human breast cancer cells (MDA-MB-231-GFP) were 
cultured in DMEM implemented with 10% fetal bovine serum 
(FBS) and penicillin (100 units/mL)/streptomycin (100 μg/mL) 
(P/S). Hank’s balanced salt solution (HBSS), supplemented with 
40 mM Hepes and 1% P/S, was used to initiate cell starvation. 
For co-culture studies, hTERT fibroblasts and MDA-MB-231-
GFP cells were plated onto glass coverslips in 12-well plates in 
These two seemingly unrelated mechanisms may also be 
intimately linked, as NFκB is both a master regulator of cyto-
kine production, and its activation is required for the induction 
of autophagy. Thus, activation of NFκB in cancer-associated 
fibroblasts could account for both the SASP and SAT. In fact, 
Figure 14. MDA-MB-231 breast cancer cell lines, which overexpress p16(INK4A) and p21(WAF1/
CIp1), show signs of senescence. (A) Cell hypertrophy. MDA-MB-231 cells, which overexpress 
p16(INK4A) and p21(WAF1/CIp1), morphologically appear flatter or hypertrophic. Representa-
tive phase images are shown. (B) Beta-galactosidase. MDA-MB-231 cells, which overexpress 
p16(INK4A) and p21(WAF1/CIp1), also appear to have increased β-galactosidase activity.
Figure 13. Generating MDA-MB-231 breast cancer cell lines, which 
overexpress p16(INK4A) and p21(WAF1/CIp1). MDA-MB-231(GFp) cells 
were transduced with lenti-viral vectors encoding p16(INK4A) and 
p21(WAF1/CIp1), and then selected for puromycin-resistance. Control 
cells transduced with the empty vector (eV; Lv-105) were produced in 
parallel. then, these stable cell lines were subjected to biochemical 
analysis. Note the overexpression of markers of cell cycle arrest and se-
nescence [p16(INK4A, p21(WAF1/CIp1) and β-galactosidase] is observed. 
Blotting with β-actin is shown as a control for equal protein loading.
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complete media at a cellular ratio of 5:1. The next day, the media 
was switched to DMEM supplemented with 10% NuSerum. 
Cells were maintained in co-culture for 3 d.
Lenti-virus production and cell line derivation. For lenti-
virus production, 293Ta cells were transfected with different 
plasmids, in particular, EX-neg-Lv105 (the empty vector control), 
EX-H0288-Lv105 (encoding p19), EX-T2276-Lv105 (encoding 
smARF), EX-T1759-Lv105 (encoding p16) and EX-G0313-Lv105 
(encoding p21). All plasmids also contained a puromycin-resis-
tance marker. The resulting lenti-viruses were then used to infect 
hTERT fibroblasts or MDA-MB-231-GFP cells to obtain stable 
cell lines overexpressing the target gene of interest.
Immunoblot analysis. Immunoblotting was performed on 
samples obtained through OG buffer extraction. For this pur-
pose, cells were scraped in OG lyses buffer (10 mM Tris, pH 
7.5, 150 mM NaCl, 1% Triton X-100 and 60 mM n-octyl-glu-
coside), supplemented with a protease-inhibitor cocktail (Roche 
Diagnostics) and a phosphatase-inhibitor cocktail (Sigma). The 
samples were rotated for 40 min, then centrifuged for 10 min 
at 13,000 × g at 4°C. Finally, supernatants were collected. To 
determine the expression of cell cycle-related proteins, 
the cells were scraped into RIPA buffer (50 mM Tris pH 
7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycho-
late, 0.1% SDS, plus protease-inhibitor and phospha-
tase-inhibitor cocktails) and sonicated for 20 sec, then 
the samples were centrifuge 13,000 × g for 10 min at 
4°C, and the supernatants were collected. The protein 
concentrations were determined using the BCA protein 
assay kit (Thermo scientific, #23225). Protein lysates 
were then separated by SDS-PAGE (using a 10-to-15% 
acrylamide gel) and transferred to nitrocellulose mem-
branes. To detect expression of the protein of interest, 
specific primary antibodies and peroxidase-conjugated 
secondary antibodies were used. Bound antibodies were 
revealed using enhanced chemiluminescence (ECL) 
substrates (Thermo Scientific).
L-lactate assays. L-lactate levels were assessed 
according to the manufacturer’s instructions, using the 
EnzyChromTM L-Lactate assay kit (cat #ECLC-100, 
BioAssay Systems). For this purpose, cells were seeded 
in 12-well plates in complete media. The next day, the 
media was switched to DMEM containing 2% FBS. 
After 48 h, the media was collected, and the concentra-
tion of L-lactate was measured. Results were normalized 
for total cell number.
β-galactosidase staining assay. β-galactosidase 
activity was also detected by using a Senescence 
β-galactosidase staining kit (Cell Signaling, #9860). 
Figure 15. MDA-MB-231 breast cancer cell lines, which overexpress 
p16(INK4A) and p21(WAF1/CIp1), undergo autophagy, and show dramat-
ically reduced tumor growth. (A) Autophagy status. MDA-MB-231 cells, 
which overexpress p16(INK4A) and p21(WAF1/CIp1), undergo increased 
authophagy, either at baseline (Lamp-1, BNIp3, LC3-I/II) or under condi-
tions of starvation for 12 h with HBSS (Beclin-1 and cathepsin B). (B) 
tumor growth. MDA-MB-231 cells, which overexpress p16(INK4A) and 
p21(WAF1/CIp1), show a near 2-fold reduction in tumor volume.
Figure 16. Understanding cell cycle arrest, senescence and autophagy: the 
sensescence-autophagy transition (SAt). previously, we showed that recombi-
nant expression of autophagy-associated genes (BNIp3, cathepsin B or AtG16L1) 
is sufficient to induce senescence, driving the autophagy-senescence transition 
(ASt). Here, we show that recombinant expression of CDK inhibitors (p16/p19/p21) 
is sufficient to induce autophagy, driving the senescence-autophagy transition 
(SAt). Both SAt and ASt result in mitochondrial dysfunction and a metabolic shift 
toward glycolysis, “powering down” cells during cell cycle arrest. thus, cell cycle 
arrest, autophagy and senescence are all part of the same metabolic program that 
occurs in response to cellular stress.
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and incubated overnight at 4°C with rat monoclonal CD31 
antibody (550274, BD Biosciences). The sections were then 
incubated with biotinylated rabbit anti-rat IgG (Vector Labs) 
and streptavidin-HRP (Dako). Immunoreactivity was revealed 
with 3, 3' diaminobenzidine. For quantitation of vessels, CD31-
positive vessels were counted in 6–8 fields within the central area 
of each tumor using a 20x objective lens and an ocular grid (0.25 
mm2 per field). The total numbers of vessel per unit area was 
calculated and the data was represented graphically.
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For this purpose, cells were seeded into 6-well plates in complete 
media. After 24 h, the media was changed to DMEM supple-
mented with 10% Nu-serum. After 48 h, the cells were fixed and 
incubated overnight at 37°C in a dry incubator without CO
2
 
with the β-galactosidase Staining solution. Afterwards, cells were 
observed under the microscope.
Cellular hypertrophy assay. Approximately 100,000 cells 
were seeded per well in 12-well plates in DMEM containing 10% 
FBS. The next day, the media was switched to DMEM supple-
mented with 10% Nu-serum. After 24 h, cells were counted and 
protein lysates were prepared with OG buffer. Protein quantifi-
cation was performed using the BCA protein assay kit (Thermo 
scientific, #23225). The values obtained were expressed as a ratio 
between the total amount of protein per well and the total num-
ber of cells per well (protein/cell number). An increased protein/
cell number ratio would be indicative of cellular hypertrophy.
Animal studies. To evaluate the in vivo tumor-promoting 
effects of CDK-inhibitor proteins, flank injections were per-
formed on athymic NCr nude mice (NCRNU; Taconic Farms; 
at 6–8 wk of age). Experiments were performed according to the 
National Institutes of Health (NIH) guidelines, with the con-
sensus of the Institutional Animal Care and Use Committee 
(IACUC) of Thomas Jefferson University. MDA-MB-231-GFP 
cells (alone or plus hTERT-fibroblasts) were injected into the 
flanks of nude mice. More specifically, MDA-MB-231-GFP can-
cer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000 
cells) were re-suspended in 100 μl of sterile PBS, just prior to 
co-injection into the flank. After 4 wk post-injection, the tumors 
were collected and tumor growth was quantitatively measured.
Quantitation of tumor angiogenesis. Six-μm tumor frozen 
sections were fixed with 4% paraformaldehyde in PBS for 10 min 
at 4°C and washed 3x with PBS. A three-step biotin-streptavidin-
horseradish peroxidase method was used for antibody detection. 
After fixation, the sections were blocked with 10% rabbit serum 
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